U.S. Late-Day Stock Moves: MRNA, CTAS, MAXR, FGEN, AOUT

Advances:

• Moderna (MRNA) +9.5%. MRNA will join the S&P 500.
• Cintas (CTAS) +4.8%. CTAS shares were upgraded from "neutral" to "outperform" at Baird.
• Maxar Technologies (MAXR) +2%. MAXR shares were initiated as "overweight" at Morgan Stanley.

Declines:

• FibroGen (FGEN) -45.9%. The U.S. Food and Drug Administration voted against the company's treatment for anemia in chronic kidney disease treatments.
• American Outdoor Brands (AOUT) -21.5%. AOUT's fourth-quarter revenue disappointed.